New Rules

The industry trade group PhRMA has new clinical trial guidelines that take effect today, reports the Wall Street Journal Health Blog. The new rules discourage ghostwriting — "authors should identify individuals who provide writing or other assistance and disclose the funding source for this assistance" — and says that doctors who have a financial stake in a drug should not be involved in a clinical trial of that drug.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.